a public good project by the
Synthesis
Company
of California

© 2026

Shuhan Huang | doi.page

0 works0 citations0 h-index

Shuhan Huang

Nanchang University(CN)Wuhan University(CN)Second Affiliated Hospital of Nanchang University(CN)First Affiliated Hospital of Chongqing Medical University(CN)Chongqing Medical University(CN)

Publications by Year

Research Areas

Acute Ischemic Stroke Management, Cerebrovascular and Carotid Artery Diseases, Ferroptosis and cancer prognosis, Cancer Immunotherapy and Biomarkers, Venous Thromboembolism Diagnosis and Management

Most-Cited Works

→ Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients(2016)114 cited
→ Cs₄PbBr₆/CsPbBr₃ Nanocomposites for All-Inorganic Electroluminescent Perovskite Light-Emitting Diodes(2020)27 cited
→ Intravenous tirofiban therapy for patients with capsular warning syndrome(2019)24 cited
→ Safety and preliminary efficacy of intravenous tirofiban in acute ischemic stroke patient without arterial occlusion on neurovascular imaging studies(2017)24 cited
→ Enhancing Optical and Thermal Stability of Blue-Emitting Perovskite Nanocrystals through Surface Passivation with Sulfonate or Sulfonic Acid Ligands(2024)12 cited
→ The glycosylation deficiency of flavivirus NS1 attenuates virus replication through interfering with the formation of viral replication compartments

(2024)

11 cited

→ Flavivirus Concentrates Host ER in Main Replication Compartments to Facilitate Replication(2023)10 cited

→ T-Cell Lymphomas Presenting as Colon Ulcers and Eosinophilia(2015)10 cited

→ Preoperative and intraoperative tirofiban during endovascular thrombectomy in large vessel occlusion stroke due to large artery atherosclerosis(2024)10 cited

→ Effects of Oral Antiplatelet Agents and Tirofiban on Functional Outcomes of Patients with Non-Disabling Minor Acute Ischemic Stroke(2020)9 cited